Navigation Links
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Date:11/2/2009

severe or worsening signs or symptoms of these conditions should be withdrawn from therapy. In many, but not all cases, these disorders resolve after stopping PEGINTRON therapy.

Use with Ribavirin: Ribavirin may cause birth defects and death of the unborn child. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients. Ribavirin causes hemolytic anemia. The anemia associated with REBETOL therapy may result in a worsening of cardiac disease. Ribavirin is genotoxic and mutagenic and should be considered a potential carcinogen.

Contraindications

PEGINTRON is contraindicated in patients with known hypersensitivity reactions such as urticaria, angioedema, bronchoconstriction, anaphylaxis, Stevens-Johnson syndrome and toxic epidermal necrolysis to interferon alpha or any other component of the product, autoimmune hepatitis, and hepatic decompensation (Child-Pugh score > 6 [class B and C]) in cirrhotic CHC patients before or during treatment. PEGINTRON/REBETOL combination therapy is additionally contraindicated in women who are pregnant or may become pregnant (see Boxed Warning and Pregnancy section), men whose female partners are pregnant, patients with hemoglobinopathies (e.g., thalassemia major, sickle-cell anemia), and patients with creatinine clearance < 50 mL per min.

Pregnancy

REBETOL therapy should not be started until a report of a negative pregnancy test has been obtained immediately prior to planned initiation of therapy. Extreme care must be taken to avoid pregnancy in female patients and in female partners of male patients during therapy and six months post-treatment. Patients should use at least two effective forms of contraception and have monthly pregnancy tests during therapy and for six months after completion of therapy. If this drug is used during pregnancy or if a patient becomes pregnant, the patient should be apprised of the potenti
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... DULLES, Va. , April 17, 2015 ... and distribution of radiopharmaceuticals, announced today that it has ... IBA Molecular North America, Inc. (IBAM NA), to Illinois Health ... continue to operate as an independent company headquartered in ... well positioned to take advantage of new product and ...
(Date:4/17/2015)... -- TWi Pharmaceuticals, Inc. ("TWi", Stock Ticker:4180.TT) today announced ... , has obtained state sales licenses from all ... in close contact with the major nationwide retail pharmacy ... label specialty generic products sold through these nationwide pharmacy ... According to IMS Health, the U.S. pharma market ...
(Date:4/16/2015)... Calif. , April 16, 2015  Alexza Pharmaceuticals, Inc. ... quarter ended March 31, 2015 on Wednesday, May 6, 2015, ... will also host an investor conference call and live webcast ... provide a company update and discuss the financial results.  ... to www.alexza.com , under the "Investors" link.  Please log ...
Breaking Medicine Technology:Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... , PRINCETON, N.J. , Feb. 17 ... a late-stage biotechnology company, announced today that it has received ... Polymer Micelle (LPM™) technology for the improved oral delivery of ... entitled "Stabilized Reverse Micelle Compositions and Uses Thereof" covers lipid ...
... EXTON, Pa. , Feb. 16 BioTrends Research Group, ... Feraheme report, the third in a multi-phase ... iron product, Feraheme, through the first six months of product availability. ... Nephrologists and qualitative information from a subset of 15.  The reports ...
Cached Medicine Technology:Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 2Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 3Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 4Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology 5Use of AMAG's Feraheme is on the Rise with 23% of Nephrologists Reporting Use of the Product 2
(Date:4/17/2015)... 2015 Heritage Woods of McLeansboro, a ... Living Week Celebration on April 20 with a day ... mind, body and soul. , The community, which is ... older adults of all incomes, including those on Medicaid, ... Supportive Living Week is observed every April and highlights ...
(Date:4/17/2015)... 2015 Rosetta Radiology is proud to ... their list of diagnostic imaging services. This solidifies them ... the Upper East Side of Manhattan. , The new ... The addition of PET-CT, combined with Rosetta’s state of ... to work with patients through several stages of the ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 ... Dr. Kevin Sadati of the Gallery of ... Orange County’s top beauty experts. The publication focused ... lift, facial stem cell fat grafting, eyelid surgery, laser ... facial plastic surgery has resulted in thousands ...
(Date:4/17/2015)... April 17, 2015 Florida Hospital Wesley ... and Florida Hospital Carrollwood were all selected as Top ... located in Pasco County, is ranked number one for ... survey, which was conducted in partnership with an independent ... all-private bed hospital that opened in October of 2012 ...
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The ... has empowered young people to create meaningful change in their ... water and the Gospel to all of Liberia by 2020 ... and 27, students, faculty and staff raised $21,000 through the ... and the Good News of Jesus. , During the ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2
... Oct. 17 Dr. Prudence Hall,founder of The Hall ... strong,advocate for the overall health of her patients. It ... bioidentical natural hormones,that she started investigating her birth control ... of my twenty year old patients on the,pill, had ...
... food is needed, study suggests , , WEDNESDAY, Oct. 17 ... to blame, research suggests. , Scientists from the University ... dopamine, a brain chemical that helps make eating and ... more food. , "We weren,t studying obesity, per se, ...
... (NDMA) introduces platform that,leverages data contained within enterprise healthcare systems into ... ... costs, ... announced the availability of the NDMA Clinical,Intelligence Platform to all healthcare ...
... "You CAN Eat That! Awesome Food for Kids ... Oct. 17 Cooking for a child with ... separate meals. Cleveland Clinic,Press ( http://www.clevelandclinicpress.org/ ), publishing ... "You CAN Eat That!,Awesome Food for Kids with ...
... workflow and data connectivity for ... Cardiac ... CSCX ), a global leader in advanced cardiac monitoring,and ... Tel RMS(R) 3.0, now has seamless connectivity with LUMEDX,CardioWellness(TM) data ...
... numbers are staggering --,over 20% of people living in ... the impairment or disability which creates dependency and,poverty in ... and political opportunities," says Ron Nabors, Chief,Executive Officer of ... stand up and speak out on the,International Day for ...
Cached Medicine News:Health News:Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients 2Health News:Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients 3Health News:Genes Might Help Drive Overeating 2Health News:Genes Might Help Drive Overeating 3Health News:NDMA Launches Clinical Intelligence Platform 2Health News:New Cleveland Clinic Press Healthy Cookbook Helps Diabetic Kids 2Health News:Cardiac Science Announces Data Connectivity with LUMEDX 2Health News:Cardiac Science Announces Data Connectivity with LUMEDX 3Health News:Cardiac Science Announces Data Connectivity with LUMEDX 4Health News:CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty 2
The Urine Legionella Antigen ELISA kit detects the presence of Legionella pneumophila serogroup1 antigen in urine....
Measles IgM ELISA....
Toxoplasma IgG II ELISA...
Herpes Simplex Virus Group IgG....
Medicine Products: